Key result
Deleting the IBV PL1pro domain cuts viral replication ~99% vs wild-type by restoring innate immunity.
Why the study?
The function of the proteolytically defective PL1pro in infectious bronchitis virus (IBV) replication and immune evasion remains largely unknown.
Absolute Event Rate: 4.58% vs 6.44%
p-value: p=0.012
IBV PL1pro is essential for viral replication and evasion of host innate immunity, suggesting it may be a viable target for antiviral therapies.
PL1pro-deficient IBV recombinants are viable; leaves open the protease's role in replication and immune evasion for further study.
BACKGROUND: Coronavirus papain-like proteases (PLpros) play a crucial role in virus replication and the evasion of the host immune response. Infectious bronchitis virus (IBV) encodes a proteolytically defective remnant of PL1pro and an active PL2pro. However, the function of PL1pro in IBV remains largely unknown. This study aims to explore the effect of PL1pro on virus replication and underlying mechanisms. RESULTS: The recombinant viruses rIBV-ΔPL1pro and rIBV-ΔPL1pro-N were obtained using reverse genetic techniques through the deletion of the IBV PL1pro domain and the N-terminal conserved sequence of PL1pro (PL1pro-N). We observed significantly lower replication of rIBV-ΔPL1pro and rIBV-ΔPL1pro-N than wild-type IBV. Further investigation revealed that the lack of PL1pro-N in IBV decreased virus resistance to interferon (IFN) while also inducing host immune response by enhancing the production of IFN-β and activating the downstream STAT1 signaling pathway of IFNs. In addition, the overexpression of PL1pro-N significantly suppressed type I IFN response by down-regulating the expressions of genes in the IFN pathway. CONCLUSIONS: Our data demonstrated that IBV PL1pro plays a crucial role in IBV replication and the suppression of host innate immune responses, suggesting that IBV PL1pro could serve as a promising molecular target for antiviral therapy.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2023) studied Infectious bronchitis virus (IBV) infection. Deletion of IBV PL1pro domain (rIBV-ΔPL1pro) vs. Wild-type IBV (rIBV) was evaluated on Virus titer (log10 PFU/ml) (p=0.012). Deletion of the IBV PL1pro domain significantly reduced virus replication compared to wild-type IBV, demonstrating its crucial role in viral replication and suppression of host innate immune responses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: